Home > National Drug Code (NDC) > Terazosin Hydrochloride

Terazosin Hydrochloride - 21695-813-90 - (Terazosin Hydrochloride)

Alphabetical Index


Drug Information of Terazosin Hydrochloride

Product NDC: 21695-813
Proprietary Name: Terazosin Hydrochloride
Non Proprietary Name: Terazosin Hydrochloride
Active Ingredient(s): 5    mg/1 & nbsp;   Terazosin Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Terazosin Hydrochloride

Product NDC: 21695-813
Labeler Name: Rebel Distributors Corp
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075317
Marketing Category: ANDA
Start Marketing Date: 20090701

Package Information of Terazosin Hydrochloride

Package NDC: 21695-813-90
Package Description: 90 CAPSULE in 1 BOTTLE (21695-813-90)

NDC Information of Terazosin Hydrochloride

NDC Code 21695-813-90
Proprietary Name Terazosin Hydrochloride
Package Description 90 CAPSULE in 1 BOTTLE (21695-813-90)
Product NDC 21695-813
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Terazosin Hydrochloride
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20090701
Marketing Category Name ANDA
Labeler Name Rebel Distributors Corp
Substance Name TERAZOSIN HYDROCHLORIDE
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of Terazosin Hydrochloride


General Information